Using the publicly available ImmPort database, researchers standardized and analyzed immune-related data for more than 10,300 healthy individuals.
As interest in personalized medicine grows, government contractors are entering the field, the Washington Post reports.
Last month, during a forum organized by US News & World Report, Amy Caro, vice president of health IT programs at Northrop
Northrop Grumman received the award under the BioWatch Gen-3 System Performance Demonstration Contract, and said that the contract could be worth up to $37 million over three years.
Agilent Technologies, Columbia University, and others are collaborating on development of the system, which will be based on MassTag PCR.
The firms won grants to develop integrated diagnostic systems used to counter natural or man-made biological threats.
The companies will use Luminex's xMAP technology to develop an automated biothreat detection tool for a US biosecurity network.
Nebula Genomics is launching its genome sequencing service for free for people who provide certain information about themselves, the Boston Globe reports.
In PLOS this week: grey wolf population genomics, mutations associated with lung adenocarcinoma survival, and more.
An opinion piece at Bloomberg discusses China's stance on genomic research.
Genetic ancestry testing can affect a person's sense of identity, the New York Times Magazine writes.